The transgenic construct contains the reverse tetracycline-controlled transactivator (rtTA*M2) protein under the control of the 13Kb (7.3kb upstream of, and 5.7kb downstream of the transcription start site) mouse villin 1 promoter. Founder line 5 (V5) expression is observed in the intestinal crypt-villus axis. (J:211832)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count